MedTrace Logo

Pupillometry Guided Remifentanil Administration and Total Opioid Consumption During Propofol - Remifentanil TCI

NCT02576600 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2015-10-19

No results posted yet for this study

Summary

The aim of this prospective randomized study was to evaluate the impact of peroperative pupillometry monitoring on per and post-operative opioid consumption in major gynecological surgery. All patients were anesthetized with TCI of propofol and remifentanil. In the intervention group, peroperative remifentanil target was guided by pupillometry. In the other group, remifentanil was administered according to standard practice.

Conditions

Interventions

DEVICE

Videopupillometer Algiscan

pupillary diameter measurement every five minutes per-operatively

OTHER

Standard practice

remifentanil administration left to the discretion of the anesthesiologist in charge according to standard practice

DRUG

Propofol

TCI

DRUG

Remifentanil

TCI

Sponsors & Collaborators

  • Pr Isabelle CONSTANT

    lead OTHER

Principal Investigators

  • Isabelle Constant, MD-PHD · Hôpital Armand Trousseau

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-12-31
Completion
2013-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02576600 on ClinicalTrials.gov